Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 91-100 of 134

Page
per page
  1. AI-3
    B7761 AI-3
    Summary: Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor
      <14.64 mg/mL
  2. Gardiquimod
    C5785 Gardiquimod
    Summary: agonist of human toll-like receptor 7 (TLR7)
      ≤12 mg/mL
  3. Anti-Inflammatory Peptide 1
    A1008 Anti-Inflammatory Peptide 1
    Summary: PLA2 inhibitor
      ≥107.9 mg/mL
  4. Myelopeptide-2 (MP-2)
    A1010 Myelopeptide-2 (MP-2)
    Summary: Peptide used for restoring human T lymphocytes
      ≥77.5 mg/mL
  5. a-MSH, amide
    A1025 a-MSH, amide
    Summary: Melanocyte-stimulating hormones
      insoluble in EtOH; ≥10.44 mg/mL
  6. β-Interleukin I (163-171), human
    A1026 β-Interleukin I (163-171), human
    Summary: T cell activator
      insoluble in EtOH; ≥100.4 mg/mL
  7. β-Interleukin II (44-56)
    A1027 β-Interleukin II (44-56)
    Summary: Cytokine,regulating WBC
      insoluble in EtOH; ≥150 mg/mL
  8. Interleukin II (60-70)
    A1030 Interleukin II (60-70)
    Summary: Cytokine,regulating WBC
      insoluble in EtOH; ≥11.34 mg/mL
  9. Papain Inhibitor
    A1035 Papain Inhibitor
    Target: Papains
    Summary: Inhibitor of peptidase activity of Papain
      insoluble in EtOH; ≥45.1 mg/mL
  10. alpha-1 antitrypsin fragment
    A1051 alpha-1 antitrypsin fragment
    Summary: Protease inhibitor
      insoluble in EtOH; insoluble in H2O; ≥45.1 mg/mL

Items 91-100 of 134

Page
per page